SEC accuses lawyers in $1.7m PixarBio fraud

In case you missed it

• Where are the world’s medtech headquarters?
• Tandem Diabetes Care touts real-world t:slim X2 insulin pump data
• FDA clears Viseon’s Voyant spine surgery imaging device
• Covalon closes $6m private placement
• LimFlow wins FDA nod for pDVA trial in chronic limb-threatening ischemia
• Globus acquires StelKast for $28.4m
• The 10 largest medical device companies in the world
• STeP would make treatments for non-life-threatening conditions safer
• Pulmatrix doses first patient in Pulmazole trial
• Dexcom adds COO to CFO Blackford’s title | Personnel Moves, September 19, 2019
• Understanding budgets, extra costs and feasibility in clinical research
• West Virginia AG sues Johnson & Johnson over pelvic mesh
• Merit Medical closes $50m BrightWater buyout
• Astellas, Iota ink wireless implant pact
• Avalign pays $10m to settle fraud charges in uncleared devices case
• SetPoint Medical looks to raise $20.5 million for pivotal trial
• Ex-Bard CEO Ring surfaces with $30m medtech fund for low-resource areas